What is the recommended dose of dyphylline for a 41kg adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dyphylline Dosing for a 41kg Adult

For a 41kg adult, administer dyphylline at 15 mg/kg per dose, which equals approximately 615 mg per dose, given twice daily (BID), with a maximum single dose not exceeding 1000 mg.

Dosing Calculation and Administration

  • The standard adult dosing for dyphylline is 15 mg/kg per dose administered twice daily, which for a 41kg patient calculates to approximately 615 mg per dose 1, 2.

  • Dyphylline can be administered via oral tablet, oral solution, or intramuscular injection with equivalent bioavailability, as absorption is rapid and independent of route or formulation 1, 2.

  • The dosing interval should be every 12 hours (BID) due to dyphylline's short half-life of approximately 2.1-2.6 hours 1, 2.

Pharmacokinetic Considerations

  • Dyphylline reaches peak serum concentration (Cmax) rapidly: within 20-40 minutes for oral solutions and approximately 40 minutes for tablets 2.

  • The drug has a volume of distribution of approximately 0.5 L/kg and total body clearance of 0.11 L/kg/hr, which supports the twice-daily dosing regimen 3.

  • Unlike theophylline, dyphylline does not require routine plasma monitoring except in patients with hepatic insufficiency or documented intolerance to xanthine drugs 4.

Maximum Dosing and Safety

  • The maximum recommended single dose is 1000 mg, even though this patient's calculated dose (615 mg) falls well below this threshold 4.

  • Dyphylline produces stable serum concentrations and has a significantly better side effect profile compared to theophylline, with only 5% of patients reporting moderate adverse effects in retrospective studies 4.

Important Clinical Caveats

  • Dyphylline has a narrow evidence base for proven efficacy, and current dosage recommendations have been questioned in the literature due to its short half-life 1.

  • Bioavailability is consistent across formulations (solution, regular tablet, sustained-release), so formulation choice can be based on patient preference and availability 2.

  • In lactating women, dyphylline distributes into breast milk at twice the serum concentration (milk/serum ratio of 2.08), which is a consideration if applicable 3.

References

Research

The pharmacokinetics of dihydroxypropyltheophylline: a basis for rational therapy.

The Journal of allergy and clinical immunology, 1975

Research

Pharmacokinetics and bioavailability of three dyphylline preparations.

European journal of clinical pharmacology, 1983

Research

Doxofylline: The next generation methylxanthine.

Indian journal of pediatrics, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.